Results for
"[search-keyword]"
Sponsor content
7 result(s) found, displaying 1 to 7
-
Jul-2024Prescription medicine evaluationActive ingredient: pegcetacoplan.
-
Australian Public Assessment Report (AusPAR)Doptelet (avatrombopag) has been approved for the treatment of thrombocytopenia in adult patients with chronic liver disease and chronic immune thrombocytopenia.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for DOPTELET avatrombopag (as maleate) 20 mg film-coated tablets blister pack.
-
Prescription medicine decision summaryDoptelet (avatrombopag maleate) is approved to treat thrombocytopenia in adult patients.
-
Prescription medicine registrationActive ingredients: avatrombopag maleate.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for EMPAVELI pegcetacoplan 1080 mg/20 mL injection solution vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for KINERET anakinra 100mg/0.67mL solution for injection prefilled syringe.